AE

Loading...

Cytonus Therapeutics to meet with the FDA in 2020 with its immuno-oncology platform technology

263 views

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 14, 2020

Cytonus Therapeutics Inc CEO Dr Remo Moomiaie-Qajar chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Based in Columbus, Ohio, the cell-based platform technology company is focused on immuno-oncology and gene therapies for cancer and rare diseases.

Comments are turned off
When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...